Cargando…

Weight Gain after Interferon-Free Treatment of Chronic Hepatitis C—Results from the German Hepatitis C-Registry (DHC-R)

Chronic hepatitis C can be treated very effectively with direct-acting antivirals (DAA) with only minor side effects compared to an interferon-containing treatment regimen. The significance of metabolic comorbidities after HCV cure is not well defined. This study aims to investigate short- and long-...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlevogt, Bernhard, Boeker, Klaus H. W., Mauss, Stefan, Klinker, Hartwig, Heyne, Renate, Link, Ralph, Simon, Karl-Georg, Sarrazin, Christoph, Serfert, Yvonne, Manns, Michael P., Wedemeyer, Heiner
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533115/
https://www.ncbi.nlm.nih.gov/pubmed/34680612
http://dx.doi.org/10.3390/biomedicines9101495
_version_ 1784587233913733120
author Schlevogt, Bernhard
Boeker, Klaus H. W.
Mauss, Stefan
Klinker, Hartwig
Heyne, Renate
Link, Ralph
Simon, Karl-Georg
Sarrazin, Christoph
Serfert, Yvonne
Manns, Michael P.
Wedemeyer, Heiner
author_facet Schlevogt, Bernhard
Boeker, Klaus H. W.
Mauss, Stefan
Klinker, Hartwig
Heyne, Renate
Link, Ralph
Simon, Karl-Georg
Sarrazin, Christoph
Serfert, Yvonne
Manns, Michael P.
Wedemeyer, Heiner
author_sort Schlevogt, Bernhard
collection PubMed
description Chronic hepatitis C can be treated very effectively with direct-acting antivirals (DAA) with only minor side effects compared to an interferon-containing treatment regimen. The significance of metabolic comorbidities after HCV cure is not well defined. This study aims to investigate short- and long-term weight change of patients receiving interferon-free antiviral treatment for chronic hepatitis C. The German Hepatitis C-registry (DHC-R) is a national multicenter real-world cohort. A total of 5111 patients were followed prospectively after DAA treatment for up to 3 years. Weight change compared to baseline was analyzed at end of treatment and at years 1, 2, and 3 after completion of antiviral therapy. Regression analysis was performed to identify baseline predictors for weight change. While there was no relevant mean weight change (−0.2 kg, SD 4.3 kg) at the end of antiviral treatment, weight started to increase during long-term follow-up reaching +1.7 kg (SD 8.0 kg, p < 0.001) compared to baseline at 3 years (follow-up year 3, FU3) after completion of antiviral therapy. 48%, 31%, and 22% of patients had a weight gain greater than 1, 3, and 5 kg at FU3, respectively. During follow-up, a body mass index (BMI) <30 proved to be the only consistent predictor for weight gain. DAA treatment is followed by a substantial weight gain (+3 kg or more) in one-third of the patients during long-term follow-up. Non-obese patients seemed to be most vulnerable to weight gain. The body compartment involved in weight gain as well as the mechanism of weight gain remain to be elucidated.
format Online
Article
Text
id pubmed-8533115
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85331152021-10-23 Weight Gain after Interferon-Free Treatment of Chronic Hepatitis C—Results from the German Hepatitis C-Registry (DHC-R) Schlevogt, Bernhard Boeker, Klaus H. W. Mauss, Stefan Klinker, Hartwig Heyne, Renate Link, Ralph Simon, Karl-Georg Sarrazin, Christoph Serfert, Yvonne Manns, Michael P. Wedemeyer, Heiner Biomedicines Article Chronic hepatitis C can be treated very effectively with direct-acting antivirals (DAA) with only minor side effects compared to an interferon-containing treatment regimen. The significance of metabolic comorbidities after HCV cure is not well defined. This study aims to investigate short- and long-term weight change of patients receiving interferon-free antiviral treatment for chronic hepatitis C. The German Hepatitis C-registry (DHC-R) is a national multicenter real-world cohort. A total of 5111 patients were followed prospectively after DAA treatment for up to 3 years. Weight change compared to baseline was analyzed at end of treatment and at years 1, 2, and 3 after completion of antiviral therapy. Regression analysis was performed to identify baseline predictors for weight change. While there was no relevant mean weight change (−0.2 kg, SD 4.3 kg) at the end of antiviral treatment, weight started to increase during long-term follow-up reaching +1.7 kg (SD 8.0 kg, p < 0.001) compared to baseline at 3 years (follow-up year 3, FU3) after completion of antiviral therapy. 48%, 31%, and 22% of patients had a weight gain greater than 1, 3, and 5 kg at FU3, respectively. During follow-up, a body mass index (BMI) <30 proved to be the only consistent predictor for weight gain. DAA treatment is followed by a substantial weight gain (+3 kg or more) in one-third of the patients during long-term follow-up. Non-obese patients seemed to be most vulnerable to weight gain. The body compartment involved in weight gain as well as the mechanism of weight gain remain to be elucidated. MDPI 2021-10-19 /pmc/articles/PMC8533115/ /pubmed/34680612 http://dx.doi.org/10.3390/biomedicines9101495 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Schlevogt, Bernhard
Boeker, Klaus H. W.
Mauss, Stefan
Klinker, Hartwig
Heyne, Renate
Link, Ralph
Simon, Karl-Georg
Sarrazin, Christoph
Serfert, Yvonne
Manns, Michael P.
Wedemeyer, Heiner
Weight Gain after Interferon-Free Treatment of Chronic Hepatitis C—Results from the German Hepatitis C-Registry (DHC-R)
title Weight Gain after Interferon-Free Treatment of Chronic Hepatitis C—Results from the German Hepatitis C-Registry (DHC-R)
title_full Weight Gain after Interferon-Free Treatment of Chronic Hepatitis C—Results from the German Hepatitis C-Registry (DHC-R)
title_fullStr Weight Gain after Interferon-Free Treatment of Chronic Hepatitis C—Results from the German Hepatitis C-Registry (DHC-R)
title_full_unstemmed Weight Gain after Interferon-Free Treatment of Chronic Hepatitis C—Results from the German Hepatitis C-Registry (DHC-R)
title_short Weight Gain after Interferon-Free Treatment of Chronic Hepatitis C—Results from the German Hepatitis C-Registry (DHC-R)
title_sort weight gain after interferon-free treatment of chronic hepatitis c—results from the german hepatitis c-registry (dhc-r)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533115/
https://www.ncbi.nlm.nih.gov/pubmed/34680612
http://dx.doi.org/10.3390/biomedicines9101495
work_keys_str_mv AT schlevogtbernhard weightgainafterinterferonfreetreatmentofchronichepatitiscresultsfromthegermanhepatitiscregistrydhcr
AT boekerklaushw weightgainafterinterferonfreetreatmentofchronichepatitiscresultsfromthegermanhepatitiscregistrydhcr
AT maussstefan weightgainafterinterferonfreetreatmentofchronichepatitiscresultsfromthegermanhepatitiscregistrydhcr
AT klinkerhartwig weightgainafterinterferonfreetreatmentofchronichepatitiscresultsfromthegermanhepatitiscregistrydhcr
AT heynerenate weightgainafterinterferonfreetreatmentofchronichepatitiscresultsfromthegermanhepatitiscregistrydhcr
AT linkralph weightgainafterinterferonfreetreatmentofchronichepatitiscresultsfromthegermanhepatitiscregistrydhcr
AT simonkarlgeorg weightgainafterinterferonfreetreatmentofchronichepatitiscresultsfromthegermanhepatitiscregistrydhcr
AT sarrazinchristoph weightgainafterinterferonfreetreatmentofchronichepatitiscresultsfromthegermanhepatitiscregistrydhcr
AT serfertyvonne weightgainafterinterferonfreetreatmentofchronichepatitiscresultsfromthegermanhepatitiscregistrydhcr
AT mannsmichaelp weightgainafterinterferonfreetreatmentofchronichepatitiscresultsfromthegermanhepatitiscregistrydhcr
AT wedemeyerheiner weightgainafterinterferonfreetreatmentofchronichepatitiscresultsfromthegermanhepatitiscregistrydhcr